A study in a monocrotaline-induced rat model of PH found that the use of HSP90 inhibitors alleviated the progression of PAH, manifested by decreased pulmonary arterial pressure and loss of right ventricular hypertrophy [74]. The gene discussed is HSP90AB1; the disease is pulmonary arterial hypertension.